Skip to main content

Advertisement

SpringerLink
Log in

Tinea Gladiatorum

Wrestling’s Emerging Foe

  • Injury Clinic
  • Published:
Sports Medicine Aims and scope Submit manuscript

Abstract

Tinea corporis, or ringworm, has become a common nuisance in competitive wrestling. Although it is a fairly benign infectious skin disease, it has significant effects on the ability of a wrestler to compete because of infection control issues. Very little has been published in the medical literature describing this problem. The majority of the literature has described outbreaks in an isolated group of wrestlers. One must examine ringworm infections in wrestlers as an entity distinct from tinea corporis infections typically seen in the paediatric population, thus the term ‘tinea gladiatorum’.

Tinea gladiatorum outbreaks have been caused by the dermatophyte, Trichophyton tonsurans. The epidemiology and microbiology point to person-to-person contact as the main source of transmission in wrestlers. The clinical features of tinea gladiatorum may or may not be consistent with those found in the general population. Ancillary tests, including potassium hydroxide preparations and fungal cultures may have to be done to confirm the diagnosis. Treatment guidelines for tinea corporis have failed to produce the desired goals in this particular population. More research studying different treatment regimens in the wrestling environment is needed to define the optimal treatment to return wrestlers to competition quickly without putting other wrestlers at risk for infection.

Intuitive hygiene practices have been suggested to prevent spread of the infection, but they have not been substantiated. Anecdotal reports suggest that hygiene practices fall short of producing adequate primary or secondary prevention. Pharmaceutical prophylaxis has been effective, but universal drug prophylaxis carries risks including drug adverse effects and potential drug resistance. The role of potential asymptomatic carriers of dermatophytes has yet to be elucidated in the origin and/or perpetuation of tinea gladiatorum outbreaks.

There are many unanswered questions about tinea gladiatorum. Sports medicine professionals must work to define this entity more completely before making recommendations about treatment, prevention and infection control. The ultimate goal is the eradication of tinea infections from the wrestling world. Energy should be focused on primary and secondary prevention, as well as treatment. Without a thorough knowledge of tinea gladiatorum as a distinct disease entity, wrestling has been losing its battle with this formidable opponent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I.
Fig. 1.
Fig. 2.
Table II.
Table III.

Similar content being viewed by others

References

  1. Cohen BA, Schmidt C. Tinea gladiatorum [letter]. N Engl J Med 1992; 327: 820

    Article  PubMed  CAS  Google Scholar 

  2. Beller M, Gessner BD. An outbreak of tinea corporis gladiatorum on a high school wrestling team. J Am Acad Dermatol 1994; 31 (2 Pt 1): 197–201

    Article  PubMed  CAS  Google Scholar 

  3. Stiller MJ, Klein WP, Dorman RI, et al. Tinea corporis gladiatorum: an epidemic of Trichophyton tonsurans in student wrestlers. J Am Acad Dermatol 1992; 27 (4): 632–3

    Article  PubMed  CAS  Google Scholar 

  4. Werninghaus K. Tinea corporis in wrestlers [letter]. J Am Acad Dermatol 1993; 28: 1022–3

    Article  PubMed  CAS  Google Scholar 

  5. Kohl TD, Martin D, Berger MS. Comparison of topical and oral treatment for tinea gladiatorum. Clin J Sport Med 1999; 9 (3): 161–6

    Article  PubMed  CAS  Google Scholar 

  6. Hradil E, Hersle K, Nordin P, et al. An epidemic of tinea corporis caused by Trichophyton tonsurans among wrestlers in Sweden. Acta Derm Venereol 1995; 75: 305–6

    PubMed  CAS  Google Scholar 

  7. Hazen PG, Weil ML. Itraconazole in the prevention and management of dermatophytosis in competitive wrestlers. J Am Acad Dermatol 1997; 36 (3 Pt 1): 481–2

    Article  PubMed  CAS  Google Scholar 

  8. Dienst WL, Dightman L, Dworkin MS, et al. Pinning down skin infections. Physician Sports Med 1997; 25 (12): 45–56

    Google Scholar 

  9. Odom R. Pathophysiology of dermatophyte infections. J Am Acad Dermatol 1993; 28 (5): S2–7

    Article  Google Scholar 

  10. Frisk A, Heilborn H, Melon B. An epidemic of tinea corporis caused by Trichophyton tonsurans among wrestlers in Sweden. Acta Derm Venereol 1966; 46: 453–6

    PubMed  CAS  Google Scholar 

  11. Kern ME, Blevins KS. Medical mycology: a self-instructional text. Philadelphia (PA): F.A. Davis Company, 1997

    Google Scholar 

  12. Kemna ME, Elewski BE. A U.S. survey of superficial fungal diseases. J Am Acad Dermatol 1996; 35 (4): 539–42

    Article  PubMed  CAS  Google Scholar 

  13. Hay RJ. Dermatophytosis and other superficial mycoses. In: Mandell GL, Douglas RG, Bennet JE, editors. Principles and practice of infectious diseases. 3rd ed. New York (NY): Churchill Livingstone, 1990: 2017–27

    Google Scholar 

  14. Knudsen EA. Experimental dermatophyte infection: the extent of fungal invasion. Acta Derm Venereol 1989; 69: 247–9

    PubMed  CAS  Google Scholar 

  15. Hebert AA, Head ES, MacDonald EM. Tinea capitis caused by Trichophyton tonsurans. Pediatr Dermatol 1985; 2: 219–23

    Article  PubMed  CAS  Google Scholar 

  16. Cohn MS. Superficial fungal infections: topical and oral treatment of common types. Postgrad Med 1992; 91 (2): 239–44

    PubMed  CAS  Google Scholar 

  17. Bergus GR, Johnson JS. Superficial tinea infections. Am Fam Physician 1993; 48 (2): 259–68

    PubMed  CAS  Google Scholar 

  18. Haldane DJ, Robart E. A comparison of calcofluor white, potassium hydroxide, and culture in the laboratory diagnosis of superficial fungal infections. Diagn Microbiol Infect Dis 1990; 13: 337–9

    Article  PubMed  CAS  Google Scholar 

  19. Drake LA, et al. Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea faciei, tinea manuum, and tinea pedis. J Am Acad Dermatol 1996; 34: 282–6

    Article  PubMed  CAS  Google Scholar 

  20. Fromtling RA. Overview of medically important antifungal azole derivatives. Clin Microbiol Rev 1988; 1: 187–217

    PubMed  CAS  Google Scholar 

  21. Smith EB. Topical antifungal drugs in the treatment of tinea pedis,tinea cruris, and tinea corporis. J Am Acad Dermatol 1993; 28: S24–8

    Article  Google Scholar 

  22. Gupta AK, Sander DN, Shear NH. Antifungal agents: an overview. Part II. J Am Acad Dermatol 1994; 30: 911–33

    Article  PubMed  CAS  Google Scholar 

  23. Friedlander SF. The evolving role of itraconazole, fluconazole, and terbenifine in the treatment of tinea capitis. Pediatr Infect Dis J 1999; 18 (2): 205–10

    Article  PubMed  CAS  Google Scholar 

  24. Cauwenbergh G, Degreef H, Heykants J, et al. Pharmacokinetic profile of orally administered itraconazole in human skin. J Am Acad Dermatol 1988; 18: 263–8

    Article  PubMed  CAS  Google Scholar 

  25. Willemsen M, DeDonecker P, Willems J, et al. Posttreatment itraconazole levels in the nail. J Am Acad Dermatol 1992; 26: 731–5

    Article  PubMed  CAS  Google Scholar 

  26. Faergemann J, Laufen H. Levels of fluconazole in serum, stratum corneum, epidermis-dermis (without stratum corneum) and eccrine sweat. Clin Exp Dermatol 1993; 18 (2): 102–6

    Article  PubMed  CAS  Google Scholar 

  27. Haneke E. Fluconazole levels in human epidermis and blister fluid. Br J Dermatol 1990: 123: 273–7

    Article  PubMed  CAS  Google Scholar 

  28. Faergemann J, Zehender H, Jones T, et al. Terbenifine levels in serum,stratum corneum, dermis-epidermis (without stratum corneum) and eccrine sweat. Acta Derm Venereol 1991; 71 (4): 322–6

    PubMed  CAS  Google Scholar 

  29. Bourland A, Lachapelle JM, Aussems J, et al. Double-blind comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris. Int J Dermatol 1989; 28: 410–2

    Article  Google Scholar 

  30. Hernanz ADP, Gomez SL, Lastra FG, et al. A comparative double-blind study of terbenifine and griseofulvin in tinea corporis and tinea cruris. Clin Exp Dermatol 1990; 15: 210–6

    Article  Google Scholar 

  31. Roberts WO. Specific problems and pearls in wrestling. American College of Sports Medicine Team Physician II Course; 1999 Feb 24–28; San Antonio, 14

  32. Goodman RA, Thacker SB, Solomon SL, et al. Infectious disease in competitive sports. JAMA 1994; 271 (11): 862–7

    Article  PubMed  CAS  Google Scholar 

  33. Sevier TL. Infectious diseases in athletes. Med Clin North Am 1993; 78 (2): 389–412

    Google Scholar 

  34. Scheinberg RS. Stopping skin assailants: fungi, yeasts, and viruses. Physician Sports Med 1994; 22: 33–9

    Google Scholar 

Download references

Disclaimer: The material presented in this review article is the work of the authors based upon their study and review of the literature. It in no way represents the views or ideas of the United States Air Force or the Department of Defense.

Dr Kohl would like to thank colleagues David Martin, MD and Richard Nemeth, MD who have helped him to uncover information about tinea gladiatorum. Special gratitude is extended to Dan Giesen, ATC, John Moyer, ATC, Todd Bartley MS, ATC, Glenn Thompson, MEd, ATC, Terry Ventresca, ATC, Jennifer Ganter, MEd, ATC, Jennifer Motze, ATC and Matthew Blimline, ATC for their assistance in developing and implementing research in this area. A final thank you to D. Michael Baxter, MD and Marc S. Berger, MD for their support of the research and study needed to produce this paper.

Author information

Authors and Affiliations

  1. First Medical Group, Langley Air Force Base, Virginia, USA

    Thomas D. Kohl

  2. Reading Hospital and Medical Center, Family Medicine Residency, Reading, Pennsylvania, USA

    Thomas D. Kohl & Mary Lisney

Authors
  1. Thomas D. Kohl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary Lisney
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas D. Kohl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kohl, T.D., Lisney, M. Tinea Gladiatorum. Sports Med 29, 439–447 (2000). https://doi.org/10.2165/00007256-200029060-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00007256-200029060-00006

Keywords

Search

Navigation